Stroke thrombolysis and the third international stroke trial: examining 'the totality of the evidence'

dc.contributor.authorKleinig, T.J.
dc.contributor.authorChurilov, L.
dc.contributor.authorParsch, C.S.
dc.contributor.authorDewey, H.M.
dc.contributor.authorBarber, P.A.
dc.date.issued2013
dc.descriptionEditorial
dc.description.statementofresponsibilityTimothy John Kleinig, Leonid Churilov, Cathrin Sibylle Parsch, Helen M Dewey and P Alan Barber
dc.identifier.citationEMA - Emergency Medicine Australasia, 2013; 25(2):107-109
dc.identifier.doi10.1111/1742-6723.12046
dc.identifier.issn1742-6731
dc.identifier.issn1742-6723
dc.identifier.orcidKleinig, T.J. [0000-0003-4430-3276]
dc.identifier.urihttp://hdl.handle.net/2440/90844
dc.language.isoen
dc.publisherWiley
dc.rights© 2013 The Authors
dc.source.urihttps://doi.org/10.1111/1742-6723.12046
dc.subjectHumans
dc.subjectFibrinolytic Agents
dc.subjectHealth Knowledge, Attitudes, Practice
dc.subjectDeception
dc.subjectDissent and Disputes
dc.subjectEvidence-Based Medicine
dc.subjectInternationality
dc.subjectStroke
dc.titleStroke thrombolysis and the third international stroke trial: examining 'the totality of the evidence'
dc.typeJournal article
pubs.publication-statusPublished

Files